380 related articles for article (PubMed ID: 31320212)
1. Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains.
Pereira PS; Lima MDCA; Neto PPM; Oliveira-Tintino CDM; Tintino SR; Menezes IRA; de Oliveira JF; Marchand P; Coutinho HDM; Rodrigues MDD; da Silva TG
Bioorg Med Chem; 2019 Sep; 27(17):3797-3804. PubMed ID: 31320212
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus.
Muniz DF; Dos Santos Barbosa CR; de Menezes IRA; de Sousa EO; Pereira RLS; Júnior JTC; Pereira PS; de Matos YMLS; da Costa RHS; de Morais Oliveira-Tintino CD; Coutinho HDM; Filho JMB; Ribeiro de Sousa G; Filho JR; Siqueira-Junior JP; Tintino SR
Food Chem; 2021 Feb; 337():127776. PubMed ID: 32777574
[TBL] [Abstract][Full Text] [Related]
3. Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump.
Dantas N; de Aquino TM; de Araújo-Júnior JX; da Silva-Júnior E; Gomes EA; Gomes AAS; Siqueira-Júnior JP; Mendonça Junior FJB
Chem Biol Interact; 2018 Jan; 280():8-14. PubMed ID: 29208359
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors.
Kumar G; Goutami Godavari A; Tambat R; Kumar S; Nandanwar H; Elizabeth Sobhia M; Jachak SM
Bioorg Chem; 2020 Nov; 104():104225. PubMed ID: 32992278
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the NorA efflux pump of S. aureus by (Z)-5-(4-Fluorobenzylidene)-Imidazolidines.
Faillace MS; Alves Borges Leal AL; Araújo de Oliveira Alcântara F; Ferreira JHL; de Siqueira-Júnior JP; Sampaio Nogueira CE; Barreto HM; Peláez WJ
Bioorg Med Chem Lett; 2021 Jan; 31():127670. PubMed ID: 33161124
[TBL] [Abstract][Full Text] [Related]
6. NorA efflux pump inhibitory activity of coumarins from Mesua ferrea.
Roy SK; Kumari N; Pahwa S; Agrahari UC; Bhutani KK; Jachak SM; Nandanwar H
Fitoterapia; 2013 Oct; 90():140-50. PubMed ID: 23892000
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
Rath SK; Singh S; Kumar S; Wani NA; Rai R; Koul S; Khan IA; Sangwan PL
Bioorg Med Chem; 2019 Jan; 27(2):343-353. PubMed ID: 30552006
[TBL] [Abstract][Full Text] [Related]
8. Unlocking bacterial defense: Exploring the potent inhibition of NorA efflux pump by coumarin derivatives in Staphylococcus aureus.
Martin ALAR; Pereira RLS; Rocha JE; Farias PAM; Freitas TS; Caldas FRL; Figueredo FG; Sampaio NFL; Oliveira-Tintino CDM; Tintino SR; da Hora GCA; Lima MCP; de Menezes IRA; Carvalho DT; Coutinho HDM; Fonteles MMF
Microb Pathog; 2024 May; 190():106608. PubMed ID: 38503396
[TBL] [Abstract][Full Text] [Related]
9. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
Sabatini S; Gosetto F; Manfroni G; Tabarrini O; Kaatz GW; Patel D; Cecchetti V
J Med Chem; 2011 Aug; 54(16):5722-36. PubMed ID: 21751791
[TBL] [Abstract][Full Text] [Related]
10. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
[TBL] [Abstract][Full Text] [Related]
11. In vitro e in silico evaluation of the inhibition of Staphylococcus aureus efflux pumps by caffeic and gallic acid.
Dos Santos JFS; Tintino SR; de Freitas TS; Campina FF; de A Menezes IR; Siqueira-Júnior JP; Coutinho HDM; Cunha FAB
Comp Immunol Microbiol Infect Dis; 2018 Apr; 57():22-28. PubMed ID: 30017074
[TBL] [Abstract][Full Text] [Related]
12. Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Deka B; Suri M; Sarma S; Devi MV; Bora A; Sen T; Dihingia A; Pahari P; Singh AK
Bioorg Med Chem; 2022 Jan; 54():116580. PubMed ID: 34953341
[TBL] [Abstract][Full Text] [Related]
13. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
[TBL] [Abstract][Full Text] [Related]
14. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
[TBL] [Abstract][Full Text] [Related]
15. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
Naaz F; Khan A; Kumari A; Ali I; Ahmad F; Ahmad Lone B; Ahmad N; Ali Khan I; Rajput VS; Grover A; Shafi S
Bioorg Chem; 2021 Aug; 113():105031. PubMed ID: 34089943
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
Vidaillac C; Guillon J; Arpin C; Forfar-Bares I; Ba BB; Grellet J; Moreau S; Caignard DH; Jarry C; Quentin C
Antimicrob Agents Chemother; 2007 Mar; 51(3):831-8. PubMed ID: 17101679
[TBL] [Abstract][Full Text] [Related]
17. Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues.
Felicetti T; Cannalire R; Burali MS; Massari S; Manfroni G; Barreca ML; Tabarrini O; Schindler BD; Sabatini S; Kaatz GW; Cecchetti V
ChemMedChem; 2017 Aug; 12(16):1293-1302. PubMed ID: 28598572
[TBL] [Abstract][Full Text] [Related]
18. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C
ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel dihydronaphthalene-imidazole ligands as potential inhibitors of Staphylococcus aureus multidrug resistant NorA efflux pump: A combination of experimental and in silico molecular docking studies.
A Malik A; Dangroo NA; Kaur P; Attery S; A Rather M; Khan A; Ara T; Nandanwar H
Microb Pathog; 2024 May; 190():106627. PubMed ID: 38521473
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydroxyamines derived from lapachol and norlachol against Staphylococcus aureus strains carrying the NorA efflux pump.
Figueredo FG; Ramos ITL; Paz JA; Silva TMS; Câmara CA; de Morais Oliveira-Tintino CD; Tintino SR; de Farias PAM; Menezes IRA; Coutinho HDM; Fonteles MMF
Infect Genet Evol; 2020 Oct; 84():104370. PubMed ID: 32445918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
